Status:
COMPLETED
A Study in Subjects With Retinal Detachment
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Retinal Detachment
Phase:
PHASE1
Brief Summary
The purpose of this trial is to access the tolerability of INS37217 Intravitreal Injection when administered intravitreally in subjects with macula-on or macula-off rhegmatogenous retinal detachment (...
Eligibility Criteria
Inclusion
- have macula-on or macula-off rhegmatogenous retinal detachment
- are eligible for pneumatic retinopexy, with identifiable retinal breaks
- are phakic or pseudo-phakic
Exclusion
- have detachments not of a rhegmatogenous nature
- currently have blood in the vitreous, corneal opacity, or other conditions which limit the view of peripheral retina
- have evidence of intraocular inflammation (uveitis)
- have a history of current condition of uncontrollable, elevated IOP or open-angle glaucoma
- have breaks not conducive to a single procedure of pneumatic retinopexy treatment
- have proliferative vitreoretinopathy of type C or D
- have previously had a vitrectomy or require one
- have previously had a scleral buckle procedure
Key Trial Info
Start Date :
May 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2002
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT00210067
Start Date
May 1 2001
End Date
June 1 2002
Last Update
October 9 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.